Abstract
Aim
The aim of the present study was to assess the efficacy and safety of local application of imiquimod cream 5% for managing condylomata acuminata of the vulva in women referred to a tertiary University Hospital centre.
Method
From a total of 283 patients referred over a 3-year period, 73(26%) were treated with imiquimod.
Results
Approximately 6% failed to continue therapy due to lack of therapeutic effect whereas 71% experienced total clearance of the lesions and 85% reduction of more than 50% in the size of the condylomata. Forty-three percent of the patients observed complete response in the first 6 weeks of therapy. There were no serious adverse events encountered with mild erythema being the commonest. From the patients who were followed-up for the next 12 weeks from the completion of treatment, 13% presented recurrent warts and were managed by a different mode of therapy.
Conclusion
Imiquimod cream 5% seems to be an effective and safe method for treating condylomata acuminata of the vulva resulting possibly in lower recurrence rates than other current therapies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Becker TM, Stone KM, Alexander ER (1987) Genital human papillomavirus infection: a growing concern. Obstet Gynecol Clin North Am 14:389–396
Beutner KR, Ferenczy A (1997) Therapeutic approaches to genital warts. Am J Med 102:28–37
Beutner KR, Reitano MV, Richwald GA, Wiley DJ, AMA Expert Panel on External Genital Warts (1998) External genital warts: report of the American Medical Association Consensus Conference. Clin Infect Dis 27:796–806
Buck HW, Fortier M, Knudsen J, Paavonen J (2002) Imiquimod 5% cream in the treatment of anogenital warts in female patients. Int J Gynecol Obstet 77:231–238
Davis G, Wentworth J, Richard J (2000) Self-administered topical imiquimod treatment of vulvar intraepithelial neoplasia: a report of four cases. J Reprod Med 45:619–623
Diakomanolis E, Haidopoulos D, Stefanidis K (2002) Treatment of high-grade vaginal intraepithelial neoplasia with imiquimod cream. N Engl J Med 347:374
Edwards L, Ferenczy A, Eron L, Baker D, Owens ML, Fox TL, Hougham AJ, Schmitt KA, HPV Study Group (1998) Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 134:25–30
Ferenczy A (1995) Epidemiology and clinical pathophysiology of condylomata acuminata. Am J Obstet Gynecol 172:1331–1339
Gibson SJ, Imbertson LM, Wagner TL, Testerman TL, Reiter MJ, Miller RL, Tomai MA (1995) Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609. J Interferon Cytokine Res 15:537–545
Godley M, Bradbeer C, Gellan M, Thin RN (1987) Cryotherapy compared with trichloroacetic acid in treating genital warts. Genitourin Med 63:390–392
Heaton CL (1995) Clinical manifestations and modern management of condylomata acuminata: a dermatologic perspective. Am J Obstet Gynecol 172:1345–1350
Koutsky LA, Galloway DA, Holmes KK (1988) Epidemiology of genital human papillomavirus infection. Epidemiol Rev 10:122–163
Krebs H-B, Helmkamp BF (1991) Treatment failure of genital condylomata acuminata in women: role of the male sexual partner. Am J Obstet Gynecol 165:337–340
Miller RL, Gerster JF, Owens ML, Slade HB, Tomai MA (1999) Imiquimod applied topically: a novel immune response modifier and new class of drug. Int J Immunopharmacology 21:1–14
Oriel JD (1971) Natural history of genital warts. Br J Vener Dis 47:1–3
Stone KM (1995) Human papillomavirus infection and genital warts: update on epidemiology and treatment. Clin Infect Dis 20 [Suppl 1]:S91–S97
Stone KM, Becker TM, Hadgu A, Kraus SJ (1990) Treatment of external genital warts: a randomized clinical trial comparing podophyllin, cryotherapy and electrodesiccation. Genitourin Med 66:16–19
Testerman TL, Gerster JF, Imbertson LM, Reiter MJ, Miller RL, Gibson SJ, Wagner TL, Tomai MA (1995) Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol 58:365–372
Tyring SK, Arany I, Stanley MA, Tomai MA, Miller RL, Smith MH, McDermott DJ, Slade H (1998). A randomized controlled molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis 178:551–555
Wardropper A, Wooley P (1992) Treatment of anogenital warts in genitourinary clinics in England and Wales. Int J STD AIDS 3:439–441
Weeks CE, Gibson J (1993) Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in vitro. J Interferon Res 14:93–97
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haidopoulos, D., Diakomanolis, E., Rodolakis, A. et al. Safety and efficacy of locally applied imiquimod cream 5% for the treatment of condylomata acuminata of the vulva. Arch Gynecol Obstet 270, 240–243 (2004). https://doi.org/10.1007/s00404-003-0559-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-003-0559-9